Jason Keenan

Jason Keenan, MS, CIP is the UCSF IRB Associate Director of Full Committee Reviews. In his 10 years at the UCSF IRB, Jason has been part of the review of dozens of oncology clinical trials. In the past two years, the UCSF IRB streamlined the review process for oncology clinical trials, resulting in faster times to approval. The presentation will cover the steps the IRB took to accomplish this goal.

Jasminemay Barcelon

Jasminemay Barcelon, MSc, is an Analyst of Oncology and Hematology at GlobalData in the UK. Jasminemay graduated from the University of California, Los Angeles in Physiological Sciences / Pre-Medicine with three years’ experience as a physician partner in obstetrics and gynecology and gynecology oncology publishing case studies on vaginal sarcoma in pregnancy and treatment of gestational trophoblastic neoplasia. She was concurrently a lead clinical trial coordinator for four Phase III clinical trials at UCLA gaining a breadth of knowledge on clinical trial design, patient monitoring, and regulatory reporting.  She holds a Master of Science in Cancer & Molecular and Cellular Biology from the Bart’s Cancer Institute with research focused on targeting chemoresistance in high-grade serous ovarian cancer. Jasminemay is passionate about data-driven insights and developing strategies to target unmet needs in oncology.

Baljeet Kaur

Baljeet Kaur is an Agriculture Operations Manager (AOM) for U.S. Customs and Border Protection (CBP) at the Boston Field Office (BFO) consisting of six New England States (MA, ME, VT, NH, CT, and RI).  As an AOM, Ms. Kaur is charged with providing guidance to personnel within the BFO on various agriculture matters including, but not limited to: regulated garbage compliance, regulation of biological material, and entry requirements for regulated agriculture commodities.  Ms. Kaur has more than 15 years of public service with CBP, and has worked in a variety of environments including, air passenger, air cargo, and maritime.

Tammi Acord

Tammi Acord serves as the Director of Strategic Solutions at YPrime, leveraging over two decades of expertise within the Life Sciences sector with roles in commercial (pharmaceutical & medical device), sponsor (pediatric ultra-rare), and vendor (technology) companies. With a proven track record, she excels in developing, leading, executing, and overseeing clinical development programs from inception to commercialization and drug launch. Tammi brings a unique perspective, having navigated the industry’s intricacies across the entire lifecycle, offering valuable insights into the present and future landscape. Based in the vibrant SF/Bay Area, she holds a B.S. from the University of California, Davis.

Derrick Katayama

Derrick Katayama accomplished formulation and analytical scientist with 16 years of experience in the areas of therapeutic proteins, peptides, subunit vaccines, and monoclonal antibodies. He joined Samsung Biologics team in 2022 as a Scientist of Formulation development team in CDO.

Sojeong Lee

Sojeong Lee has over 15 years of biologics process development experience specializing in mammalian cell culture including cell line development, upstream process development and pilot scale manufacturing.